Loading…
Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody
The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation,...
Saved in:
Published in: | The Journal of infectious diseases 1979-10, Vol.140 (4), p.534-540 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c353t-1745d19080a02e963af41c174d83f0d8a92d8266158cb7b98bc463c992241b963 |
---|---|
cites | |
container_end_page | 540 |
container_issue | 4 |
container_start_page | 534 |
container_title | The Journal of infectious diseases |
container_volume | 140 |
creator | Davis, William B. Taylor, John A. Oakes, John E. |
description | The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation, virus spread to the trigeminal ganglion and brain within two days and caused acute herpetic encephalitis, which killed infected animals eight to 10 days after infection. Rabbit hyperimmune antisera to HSV-1 were prepared, diluted to contain antibody at a titer of 1:150, and administered intraperitoneally to mice 8 hr after corneal infection. Administration of antisera did not interfere with the spread of HSV-l from the site of infection to the trigeminal ganglion and brain but did reduce the multiplication of virus within the central nervous system. Reduction in viral replication resulted in complete recovery of the animals that were given antibody to HSV-1. However, the animals were not protected if they were irradiated with 390 rad 24 hr prior to administration of antibody. This observation suggested that antibodymediated protection was not the result of in vivo neutralization of virus but instead required the presence of antibody as well as one or more radiation-sensitive components. |
doi_str_mv | 10.1093/infdis/140.4.534 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_74831557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30081835</jstor_id><sourcerecordid>30081835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-1745d19080a02e963af41c174d83f0d8a92d8266158cb7b98bc463c992241b963</originalsourceid><addsrcrecordid>eNo9kUtv3CAcxFHV13bbew-txCk3b8BgG3rb5rWRIiXVpmnUC8L4b4XUrwJO4q_RT1wSJ3tC4jczghmEPlOyokSyfdvVlfX7lJMVX2WMv0ILmrEiyXPKXqMFIWmaUCHle_TB-1tCCGd58Q69TVNJC75A_87N2GiHT7saTLB9h-9tuMEbcAN4vLXt0MADvrJu9PhyGgDTb_jCwR10T-K-xmszBpgNwRp81BkYbnRjg_W4nPB28gHaCNZVazvrg9MvzqfUZDuAsfWjIEaWfTV9RG9q3Xj49Hwu0c_jo8uDTXJ2fnJ6sD5LDMtYSOLzs4pKIogmKcic6ZpTE28rwWpSCS3TSqSxh0yYsiilKA3PmZEyTTkto36J9ubcwfV_R_BBtdYbaBrdQT96VXDBaJYVUUhmoXG99w5qNTjbajcpStTjCmpeQcUVFFdxhWj58pw9li1UO8Nce8RfZ3zrQ-92lBEiqIi_W6Jk5rEveNhx7f6ovGBFpjbXv9UPcnV8-Ov6uzph_wGxJ56F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74831557</pqid></control><display><type>article</type><title>Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody</title><source>Oxford University Press Archive</source><source>JSTOR Journals and Primary Sources</source><creator>Davis, William B. ; Taylor, John A. ; Oakes, John E.</creator><creatorcontrib>Davis, William B. ; Taylor, John A. ; Oakes, John E.</creatorcontrib><description>The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation, virus spread to the trigeminal ganglion and brain within two days and caused acute herpetic encephalitis, which killed infected animals eight to 10 days after infection. Rabbit hyperimmune antisera to HSV-1 were prepared, diluted to contain antibody at a titer of 1:150, and administered intraperitoneally to mice 8 hr after corneal infection. Administration of antisera did not interfere with the spread of HSV-l from the site of infection to the trigeminal ganglion and brain but did reduce the multiplication of virus within the central nervous system. Reduction in viral replication resulted in complete recovery of the animals that were given antibody to HSV-1. However, the animals were not protected if they were irradiated with 390 rad 24 hr prior to administration of antibody. This observation suggested that antibodymediated protection was not the result of in vivo neutralization of virus but instead required the presence of antibody as well as one or more radiation-sensitive components.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/140.4.534</identifier><identifier>PMID: 229174</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Animals ; Antibodies ; Antibodies, Viral - administration & dosage ; Antibody Specificity ; Antiserum ; Brain ; Central nervous system ; Encephalitis - immunology ; Encephalitis - prevention & control ; Human herpesvirus 1 ; Human resources ; Immune Sera ; Immunization ; Immunosuppression ; Infections ; Inoculation ; Keratitis, Dendritic - complications ; Major Articles ; Mice ; Rabbits ; Simplexvirus - immunology ; Trigeminal ganglion ; Virus Replication ; Viruses</subject><ispartof>The Journal of infectious diseases, 1979-10, Vol.140 (4), p.534-540</ispartof><rights>Copyright 1979 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-1745d19080a02e963af41c174d83f0d8a92d8266158cb7b98bc463c992241b963</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30081835$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30081835$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,58217,58450</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/229174$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davis, William B.</creatorcontrib><creatorcontrib>Taylor, John A.</creatorcontrib><creatorcontrib>Oakes, John E.</creatorcontrib><title>Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation, virus spread to the trigeminal ganglion and brain within two days and caused acute herpetic encephalitis, which killed infected animals eight to 10 days after infection. Rabbit hyperimmune antisera to HSV-1 were prepared, diluted to contain antibody at a titer of 1:150, and administered intraperitoneally to mice 8 hr after corneal infection. Administration of antisera did not interfere with the spread of HSV-l from the site of infection to the trigeminal ganglion and brain but did reduce the multiplication of virus within the central nervous system. Reduction in viral replication resulted in complete recovery of the animals that were given antibody to HSV-1. However, the animals were not protected if they were irradiated with 390 rad 24 hr prior to administration of antibody. This observation suggested that antibodymediated protection was not the result of in vivo neutralization of virus but instead required the presence of antibody as well as one or more radiation-sensitive components.</description><subject>Animals</subject><subject>Antibodies</subject><subject>Antibodies, Viral - administration & dosage</subject><subject>Antibody Specificity</subject><subject>Antiserum</subject><subject>Brain</subject><subject>Central nervous system</subject><subject>Encephalitis - immunology</subject><subject>Encephalitis - prevention & control</subject><subject>Human herpesvirus 1</subject><subject>Human resources</subject><subject>Immune Sera</subject><subject>Immunization</subject><subject>Immunosuppression</subject><subject>Infections</subject><subject>Inoculation</subject><subject>Keratitis, Dendritic - complications</subject><subject>Major Articles</subject><subject>Mice</subject><subject>Rabbits</subject><subject>Simplexvirus - immunology</subject><subject>Trigeminal ganglion</subject><subject>Virus Replication</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><recordid>eNo9kUtv3CAcxFHV13bbew-txCk3b8BgG3rb5rWRIiXVpmnUC8L4b4XUrwJO4q_RT1wSJ3tC4jczghmEPlOyokSyfdvVlfX7lJMVX2WMv0ILmrEiyXPKXqMFIWmaUCHle_TB-1tCCGd58Q69TVNJC75A_87N2GiHT7saTLB9h-9tuMEbcAN4vLXt0MADvrJu9PhyGgDTb_jCwR10T-K-xmszBpgNwRp81BkYbnRjg_W4nPB28gHaCNZVazvrg9MvzqfUZDuAsfWjIEaWfTV9RG9q3Xj49Hwu0c_jo8uDTXJ2fnJ6sD5LDMtYSOLzs4pKIogmKcic6ZpTE28rwWpSCS3TSqSxh0yYsiilKA3PmZEyTTkto36J9ubcwfV_R_BBtdYbaBrdQT96VXDBaJYVUUhmoXG99w5qNTjbajcpStTjCmpeQcUVFFdxhWj58pw9li1UO8Nce8RfZ3zrQ-92lBEiqIi_W6Jk5rEveNhx7f6ovGBFpjbXv9UPcnV8-Ov6uzph_wGxJ56F</recordid><startdate>197910</startdate><enddate>197910</enddate><creator>Davis, William B.</creator><creator>Taylor, John A.</creator><creator>Oakes, John E.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197910</creationdate><title>Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody</title><author>Davis, William B. ; Taylor, John A. ; Oakes, John E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-1745d19080a02e963af41c174d83f0d8a92d8266158cb7b98bc463c992241b963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>Antibodies, Viral - administration & dosage</topic><topic>Antibody Specificity</topic><topic>Antiserum</topic><topic>Brain</topic><topic>Central nervous system</topic><topic>Encephalitis - immunology</topic><topic>Encephalitis - prevention & control</topic><topic>Human herpesvirus 1</topic><topic>Human resources</topic><topic>Immune Sera</topic><topic>Immunization</topic><topic>Immunosuppression</topic><topic>Infections</topic><topic>Inoculation</topic><topic>Keratitis, Dendritic - complications</topic><topic>Major Articles</topic><topic>Mice</topic><topic>Rabbits</topic><topic>Simplexvirus - immunology</topic><topic>Trigeminal ganglion</topic><topic>Virus Replication</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davis, William B.</creatorcontrib><creatorcontrib>Taylor, John A.</creatorcontrib><creatorcontrib>Oakes, John E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davis, William B.</au><au>Taylor, John A.</au><au>Oakes, John E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1979-10</date><risdate>1979</risdate><volume>140</volume><issue>4</issue><spage>534</spage><epage>540</epage><pages>534-540</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>The effects of virus-specific antibody on the pathogenesis of infection due to herpes simplex virus type 1 (HSV-l) following corneal inoculation of young adult mice were studied. HSV-1 was inoculated onto the corneal surface immediately after trephination with a capillary pipette. After inoculation, virus spread to the trigeminal ganglion and brain within two days and caused acute herpetic encephalitis, which killed infected animals eight to 10 days after infection. Rabbit hyperimmune antisera to HSV-1 were prepared, diluted to contain antibody at a titer of 1:150, and administered intraperitoneally to mice 8 hr after corneal infection. Administration of antisera did not interfere with the spread of HSV-l from the site of infection to the trigeminal ganglion and brain but did reduce the multiplication of virus within the central nervous system. Reduction in viral replication resulted in complete recovery of the animals that were given antibody to HSV-1. However, the animals were not protected if they were irradiated with 390 rad 24 hr prior to administration of antibody. This observation suggested that antibodymediated protection was not the result of in vivo neutralization of virus but instead required the presence of antibody as well as one or more radiation-sensitive components.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>229174</pmid><doi>10.1093/infdis/140.4.534</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 1979-10, Vol.140 (4), p.534-540 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_74831557 |
source | Oxford University Press Archive; JSTOR Journals and Primary Sources |
subjects | Animals Antibodies Antibodies, Viral - administration & dosage Antibody Specificity Antiserum Brain Central nervous system Encephalitis - immunology Encephalitis - prevention & control Human herpesvirus 1 Human resources Immune Sera Immunization Immunosuppression Infections Inoculation Keratitis, Dendritic - complications Major Articles Mice Rabbits Simplexvirus - immunology Trigeminal ganglion Virus Replication Viruses |
title | Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T22%3A24%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20Infection%20with%20Herpes%20Simplex%20Virus%20Type%201:%20Prevention%20of%20Acute%20Herpetic%20Encephalitis%20by%20Systemic%20Administration%20of%20Virus-Specific%20Antibody&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Davis,%20William%20B.&rft.date=1979-10&rft.volume=140&rft.issue=4&rft.spage=534&rft.epage=540&rft.pages=534-540&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/140.4.534&rft_dat=%3Cjstor_proqu%3E30081835%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-1745d19080a02e963af41c174d83f0d8a92d8266158cb7b98bc463c992241b963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=74831557&rft_id=info:pmid/229174&rft_jstor_id=30081835&rfr_iscdi=true |